237 related articles for article (PubMed ID: 30643208)
1. Discovery of β-arrestin-biased β
Woo AY; Ge XY; Pan L; Xing G; Mo YM; Xing RJ; Li XR; Zhang YY; Wainer IW; Cheng MS; Xiao RP
Acta Pharmacol Sin; 2019 Aug; 40(8):1095-1105. PubMed ID: 30643208
[TBL] [Abstract][Full Text] [Related]
2. β
De Pascali F; Ippolito M; Wolfe E; Komolov KE; Hopfinger N; Lemenze D; Kim N; Armen RS; An SS; Scott CP; Benovic JL
Br J Pharmacol; 2022 Oct; 179(19):4692-4708. PubMed ID: 35732075
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one derivatives as potent β
Xing G; Pan L; Yi C; Li X; Ge X; Zhao Y; Liu Y; Li J; Woo A; Lin B; Zhang Y; Cheng M
Bioorg Med Chem; 2019 Jun; 27(12):2306-2314. PubMed ID: 30392952
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular modeling of 2-amino-2-phenylethanol derivatives as novel β
Ge X; Mo Y; Xing G; Ji L; Zhao H; Chen J; He B; Chen X; Xing R; Li X; Zhao Y; Li J; Yan H; Woo AY; Zhang Y; Lin B; Pan L; Cheng M
Bioorg Chem; 2018 Sep; 79():155-162. PubMed ID: 29751321
[TBL] [Abstract][Full Text] [Related]
5. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of β
Ge X; Woo AY; Xing G; Lu Y; Mo Y; Zhao Y; Lan Y; Li J; Yan H; Pan L; Zhang Y; Lin B; Cheng M
Eur J Med Chem; 2018 May; 152():424-435. PubMed ID: 29751236
[TBL] [Abstract][Full Text] [Related]
7. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
8.
Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
[No Abstract] [Full Text] [Related]
9. Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation.
Piekielna-Ciesielska J; Artali R; Azzam AAH; Lambert DG; Kluczyk A; Gentilucci L; Janecka A
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375124
[TBL] [Abstract][Full Text] [Related]
10. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of pepducins as Gs-biased allosteric agonists.
Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 8-(2-amino-1-hydroxyethyl)-6-hydroxy-1,4-benzoxazine-3(4H)-one derivatives as potent β
Yi C; Xing G; Wang S; Li X; Liu Y; Li J; Lin B; Woo AY; Zhang Y; Pan L; Cheng M
Bioorg Med Chem; 2020 Jan; 28(1):115178. PubMed ID: 31753798
[TBL] [Abstract][Full Text] [Related]
13. The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor.
Patel S; Summerhill S; Stanley M; Perros-Huguet C; Trevethick MA
Pulm Pharmacol Ther; 2011 Apr; 24(2):247-55. PubMed ID: 21134482
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening.
McAnally D; Siddiquee K; Sharir H; Qi F; Phatak S; Li JL; Berg E; Fishman J; Smith L
SLAS Discov; 2017 Aug; 22(7):867-878. PubMed ID: 28314120
[TBL] [Abstract][Full Text] [Related]
15. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
16. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β
Choi M; Staus DP; Wingler LM; Ahn S; Pani B; Capel WD; Lefkowitz RJ
Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131371
[TBL] [Abstract][Full Text] [Related]
18. Unique Positive Cooperativity Between the
Pani B; Ahn S; Rambarat PK; Vege S; Kahsai AW; Liu A; Valan BN; Staus DP; Costa T; Lefkowitz RJ
Mol Pharmacol; 2021 Nov; 100(5):513-525. PubMed ID: 34580163
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin type 1A receptor regulates β-arrestin binding of the β
Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
[TBL] [Abstract][Full Text] [Related]
20. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
